Screening Tool Artificial Intelligence-based for Predicting the Genetic Risk of BREAST Cancer (STAR-BREAST)
Sponsor: AstraZeneca
Trial Details
| Condition | Breast Neoplasms |
| Status | Recruiting |
| Participants | 800 |
| Est. Completion | 11 Aug 2026 |
| Last Updated | 29 July 2026 |
Primary Outcome
Agreement between AI tool results and genetic test results
Eligibility Criteria
Inclusion Criteria
Inclusion Criteria: * female patients, * aged 18 years or older, * identified as high genetic risk by breast surgeons, * referred to a geneticist, and * who agree to participate in the study. Exclusion Criteria: * male patients, * absence of complete information in the medical records, * patients unaware of their biological family history, and * patients who do not agree to participate in the study.
Trial Sites
Countries
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service